202 related articles for article (PubMed ID: 29274286)
1. The prevention of latanoprost on osteoclastgenesis in vitro and lipopolysaccharide-induced murine calvaria osteolysis in vivo.
Xu X; Yan Y; Liu Z; Qi J; Qian N; Zhou H; Zhou Q; Wang T; Huang P; Guo L; Jiang M; Deng L
J Cell Biochem; 2018 Jun; 119(6):4680-4691. PubMed ID: 29274286
[TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide attenuates LPS-related inflammatory osteolysis by suppressing osteoclastogenesis by reducing the MAPK signalling pathway.
Yang J; Qin L; Huang J; Li Y; Xu S; Wang H; Zhu S; Wang J; Zhu B; Li F; Huang W; Gong X; Hu N
J Cell Mol Med; 2021 Jul; 25(14):6800-6814. PubMed ID: 34080298
[TBL] [Abstract][Full Text] [Related]
3. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
[TBL] [Abstract][Full Text] [Related]
4. Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.
Yang X; Gao W; Wang B; Wang X; Guo H; Xiao Y; Kong L; Hao D
J Cell Biochem; 2017 Dec; 118(12):4479-4486. PubMed ID: 28464271
[TBL] [Abstract][Full Text] [Related]
5. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
[No Abstract] [Full Text] [Related]
6. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
7. Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.
Wei CM; Su YJ; Qin X; Ding JX; Liu Q; Song FM; Zong SH; Xu J; Zhou B; Zhao JM
Cell Physiol Biochem; 2018; 48(2):644-656. PubMed ID: 30025412
[TBL] [Abstract][Full Text] [Related]
8. Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice.
Kong L; Yang C; Yu L; Smith W; Zhu S; Zhu J; Zhu Q
PLoS One; 2013; 8(4):e61013. PubMed ID: 23613773
[TBL] [Abstract][Full Text] [Related]
9. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
11. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis.
He L; Duan H; Li X; Wang S; Zhang Y; Lei L; Xu J; Liu S; Li X
Eur J Pharmacol; 2016 May; 779():66-79. PubMed ID: 26965104
[TBL] [Abstract][Full Text] [Related]
12. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
13. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
[TBL] [Abstract][Full Text] [Related]
14. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis.
Tian B; Jiang T; Shao Z; Zhai Z; Li H; Fan Q; Liu X; Ouyang Z; Tang T; Jiang Q; Zheng M; Dai K; Qin A; Yu Y; Zhu Z
Biomaterials; 2014 Oct; 35(32):8937-50. PubMed ID: 25086794
[TBL] [Abstract][Full Text] [Related]
15. Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.
Shao S; Fu F; Wang Z; Song F; Li C; Wu ZX; Ding J; Li K; Xiao Y; Su Y; Lin X; Yuan G; Zhao J; Liu Q; Xu J
J Cell Physiol; 2019 Aug; 234(8):12701-12713. PubMed ID: 30515812
[TBL] [Abstract][Full Text] [Related]
16. Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis.
Li H; Wang J; Sun Q; Chen G; Sun S; Ma X; Qiu H; Liu X; Xu L; Liu M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469456
[TBL] [Abstract][Full Text] [Related]
17. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling.
Jiang C; Xiao F; Gu X; Zhai Z; Liu X; Wang W; Tang T; Wang Y; Zhu Z; Dai K; Qin A; Wang J
Biochimie; 2015 Apr; 111():107-18. PubMed ID: 25681755
[TBL] [Abstract][Full Text] [Related]
19. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
[TBL] [Abstract][Full Text] [Related]
20. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
